- Tytuł:
- Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
- Autorzy:
- Temat:
-
Clinical Study
bisphosphonates
bone metastases
renal cell carcinomaosteonecrosis of the jaw
outcome
targeted therapy
Cancer Research
Oncology
Concomitant
Cancer research
Tyrosine kinase
Disease free survival
Medicine
business.industry
business
Bone Density Conservation Agents
Renal cell carcinoma
medicine.disease
Pathology
medicine.medical_specialty
Protein-Tyrosine Kinases
Treatment outcome
Diphosphonates
Sciences bio-médicales et agricoles
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Bone Density Conservation Agents -- administration & dosage -- adverse effects
Bone Neoplasms -- drug therapy -- pathology -- secondary
Carcinoma, Renal Cell -- drug therapy -- pathology -- secondary
Diphosphonates -- administration & dosage -- adverse effects
Disease-Free Survival
Female
Humans
Indoles -- administration & dosage
Kidney Neoplasms -- drug therapy -- pathology
Male
Middle Aged
Neoplasm Metastasis
Niacinamide -- administration & dosage -- analogs & derivativesOsteonecrosis --chemically induced
Phenylurea Compounds -- administration & dosage
Prognosis
Protein Kinase Inhibitors -- administration & dosage
Protein-Tyrosine Kinases -- antagonists & inhibitors
Pyrroles -- administration & dosage
Retrospective Studies
Treatment Outcome
Bisphosphonates
Bone metastasesOsteonecrosis of the jaw
Outcome
Targeted therapy - Źródło:
-
British Journal of Cancer
British Journal of Cancer, 107 (10 - Opis pliku:
- 1 full-text file(s): application/pdf
- Dostępność:
-
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb22c4137af4f142fa2a48d0882b042
http://europepmc.org/articles/PMC3493858